Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Change in Acquisitions & Divestments (2018)

Palisade Bio (PALI) has disclosed Change in Acquisitions & Divestments for 4 consecutive years, with $5.0 million as the latest value for Q1 2018.

  • On a quarterly basis, Change in Acquisitions & Divestments changed N/A to $5.0 million in Q1 2018 year-over-year; TTM through Dec 2018 was $5.0 million, a N/A change, with the full-year FY2018 number at $5.0 million, changed 0.0% from a year prior.
  • Change in Acquisitions & Divestments was $5.0 million for Q1 2018 at Palisade Bio, down from $7.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $15.0 million in Q1 2015 to a low of $5.0 million in Q1 2018.
  • A 4-year average of $9.4 million and a median of $8.8 million in 2014 define the central range for Change in Acquisitions & Divestments.
  • Biggest YoY gain for Change in Acquisitions & Divestments was 49.91% in 2016; the steepest drop was 49.91% in 2016.
  • Palisade Bio's Change in Acquisitions & Divestments stood at $10.0 million in 2014, then skyrocketed by 50.07% to $15.0 million in 2015, then tumbled by 49.91% to $7.5 million in 2016, then crashed by 33.49% to $5.0 million in 2018.
  • Per Business Quant, the three most recent readings for PALI's Change in Acquisitions & Divestments are $5.0 million (Q1 2018), $7.5 million (Q1 2016), and $15.0 million (Q1 2015).